CIK 0001936258
- Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- Operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale 10% owner sold 29,846 shares at $25.54 ($762,174)
- 4 Planned sale 10% owner sold 74,910 shares at an average $25.98 ($1,945,918)
- 4 Planned sale 10% owner sold 91,068 shares at an average $25.58 ($2,329,520)
- 4 Planned sale 10% owner sold 157,234 shares at an average $25.86 ($4,066,714)
- 4 Planned sale 10% owner sold 115,480 shares at an average $25.95 ($2,996,156)
- 4 Derivatives Options or other derivatives
- 4 Planned sale 10% owner sold 191,762 shares at an average $25.34 ($4,859,875)
- 4 Planned sale 10% owner sold 462,288 shares at an average $25.40 ($11,740,618)
- 4 Planned sale 10% owner sold 41,803 shares at an average $25.07 ($1,047,876)
- 4 Planned sale 10% owner sold 10,898 shares at an average $25.01 ($272,511)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Accounting Officer sold 45,000 shares at $15.72 ($707,400)
- 4 Open-market buy Chief Business Officer bought 1,104 shares at $15.70 ($17,333)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $16.27 ($81,350)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 5 of 7 · 132 filings